Atommap Corp
Biotechnology · NEW YORK, NY
BiotechnologySEC Form D
Atommap Corp filed a Form D with the U.S. Securities and Exchange Commission on March 20, 2026, reporting $31,130,335 raised toward a $59,630,328 offering.
Incorporated in Delaware and based in NEW YORK, NY, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Atommap Corp has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Huafeng XuExecutive Officer · Director
- Keith LoebnerDirector
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised